Calcium D-Panthotenate(Calcium pantothenate)

Molecular Weight (MW)	476.53
Formula	C18H32CaN2O10
CAS No.	137-08-6
Storage	-20℃ for 3 years in powder form
-80℃ for 2 years in solvent
Solubility (In vitro)	DMSO: 44 mg/mL (92.3 mM)
Water: 44 mg/mL (92.3 mM)
Ethanol: <1 mg/mL
SMILES	O[C@@H](C(NCCC([O-])=O)=O)C(C)(C)CO.[0.5Ca2+]
Synonyms	D-Pantothenic Acid Calcium; Calcium D-pantothenate; Vitamin B5 calcium salt; Calcium pantothenate

Molecular Weight (MW)

476.53

Formula

C18H32CaN2O10

CAS No.

137-08-6

Storage

-20℃ for 3 years in powder form

-80℃ for 2 years in solvent

Solubility (In vitro)

DMSO: 44 mg/mL (92.3 mM)

Water: 44 mg/mL (92.3 mM)

Ethanol: <1 mg/mL

SMILES

O[C@@H](C(NCCC([O-])=O)=O)C(C)(C)CO.[0.5Ca2+]

Synonyms

D-Pantothenic Acid Calcium; Calcium D-pantothenate; Vitamin B5 calcium salt; Calcium pantothenate

In Vitro	In vitro activity: Pantothenic acid increases mainly the content of free glutathione, with little effect on protein-boundglutathione in human lymphoblastoic (Jurkat) cells. Pantothenic acid also increases cell respiration with pyruvate as the exogenous substrate. Pantothenic acid belongs to vitamin B group and is the building stone of coenzyme A. Pantothenic acid can be therefore infer that its beneficial effect in various kinds of cell damage by ROS is related to the increased content or stimulated biosynthesis of this coenzyme. Pantothenic acid increases the glutathione content by more than 50% and increases the GSH/GSSG ratio by approximately the same factor. Pantothenic acid and N-acetylcysteine alleviates the ultraviolet-induced decrease of glutathione content, diminished lipid peroxidation, and partly protects the cells against apoptosisproduced by ultraviolet irradiation. Cell Assay: Pantothenic acid (1 mM) increased biosynthesis of glutathione by boosting cell energetic in Jurkat cells. In addition, pantothenic acid (1 mM) protected against oxidative damage and apoptosis in Ehrlich ascites tumour cells.
In Vivo	Pantothenic acid-treated rats exhibited higher basal levels of corticosterone and progesterone than control rats in Adrenal cells. The response of ACTH and/or PRL on corticosterone and progesterone release is higher in the pantothenic acid-treated rats than in the control rats. Pantothenic acid supplementation stimulates the ability of adrenal cells in male rats to secrete corticosterone and progesterone. Pantothenic acid supplementation induces adrenalhyperresponsiveness to ACTH stimulation, and PRL further stimulated adrenal sensitivity to ACTH. Pantothenic acid prior to valproic acid (VPA) significantly protects against VPA-induced neural tube defects (NTDs) in CD-1mice. Pantothenic acid prevents VPA-induced alterations in NF-kappaB, Pim-1, and c-Myb in CD-1 mice.
Animal model	Pantothenic acid (200 mg/kg, intraperitoneal injections) completely blocked valproic acid-induced neural tube defects and the decreases in c-Myb and Pim-1 protein expression in CD-1 mice. Moreover, Calcium D-pantothenate (3.39-10.54 mg/kg, diets) increased the intestinal enzymes activities and docosahexaenoic acid (DHA) levels.
Formulation & Dosage	3.39-10.54 mg/kg, diets
References	FEBS Lett. 2004 Jul 2;569(1-3):169-72; Biofactors. 2003;17(1-4):61-73; Toxicol Appl Pharmacol. 2006 Mar 1;211(2):124-32.

In Vitro

In vitro activity: Pantothenic acid increases mainly the content of free glutathione, with little effect on protein-boundglutathione in human lymphoblastoic (Jurkat) cells. Pantothenic acid also increases cell respiration with pyruvate as the exogenous substrate. Pantothenic acid belongs to vitamin B group and is the building stone of coenzyme A. Pantothenic acid can be therefore infer that its beneficial effect in various kinds of cell damage by ROS is related to the increased content or stimulated biosynthesis of this coenzyme. Pantothenic acid increases the glutathione content by more than 50% and increases the GSH/GSSG ratio by approximately the same factor. Pantothenic acid and N-acetylcysteine alleviates the ultraviolet-induced decrease of glutathione content, diminished lipid peroxidation, and partly protects the cells against apoptosisproduced by ultraviolet irradiation.

Cell Assay: Pantothenic acid (1 mM) increased biosynthesis of glutathione by boosting cell energetic in Jurkat cells. In addition, pantothenic acid (1 mM) protected against oxidative damage and apoptosis in Ehrlich ascites tumour cells.

In Vivo

Pantothenic acid-treated rats exhibited higher basal levels of corticosterone and progesterone than control rats in Adrenal cells. The response of ACTH and/or PRL on corticosterone and progesterone release is higher in the pantothenic acid-treated rats than in the control rats. Pantothenic acid supplementation stimulates the ability of adrenal cells in male rats to secrete corticosterone and progesterone. Pantothenic acid supplementation induces adrenalhyperresponsiveness to ACTH stimulation, and PRL further stimulated adrenal sensitivity to ACTH. Pantothenic acid prior to valproic acid (VPA) significantly protects against VPA-induced neural tube defects (NTDs) in CD-1mice. Pantothenic acid prevents VPA-induced alterations in NF-kappaB, Pim-1, and c-Myb in CD-1 mice.

Animal model

Pantothenic acid (200 mg/kg, intraperitoneal injections) completely blocked valproic acid-induced neural tube defects and the decreases in c-Myb and Pim-1 protein expression in CD-1 mice. Moreover, Calcium D-pantothenate (3.39-10.54 mg/kg, diets) increased the intestinal enzymes activities and docosahexaenoic acid (DHA) levels.

Formulation & Dosage

3.39-10.54 mg/kg, diets

References

FEBS Lett. 2004 Jul 2;569(1-3):169-72; Biofactors. 2003;17(1-4):61-73; Toxicol Appl Pharmacol. 2006 Mar 1;211(2):124-32.

CAS NO:	137-08-6
规格:	≥98%

包装	价格(元)
1g	询价
2g	询价
5g	询价
10g	询价
25g	询价
50g	询价